These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14557672)

  • 1. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
    González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
    J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.
    Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
    Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
    Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
    PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
    Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
    Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
    Dégano P; Schneider J; Hannan CM; Gilbert SC; Hill AV
    Vaccine; 1999 Nov; 18(7-8):623-32. PubMed ID: 10547421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.
    Sacci JB; Hollingdale MR; Sedegah M
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28475711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.
    Fonseca JA; Cabrera-Mora M; Kashentseva EA; Villegas JP; Fernandez A; Van Pelt A; Dmitriev IP; Curiel DT; Moreno A
    PLoS One; 2016; 11(4):e0154819. PubMed ID: 27128437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi.
    Miyahira Y; Kobayashi S; Takeuchi T; Kamiyama T; Nara T; Nakajima-Shimada J; Aoki T
    Int Immunol; 1999 Feb; 11(2):133-41. PubMed ID: 10069411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
    Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
    Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
    Parra M; Liu X; Derrick SC; Yang A; Molina-Cruz A; Barillas-Mury C; Zheng H; Thao Pham P; Sedegah M; Belmonte A; Litilit DD; Waldmann TA; Kumar S; Morris SL; Perera LP
    PLoS One; 2015; 10(10):e0141141. PubMed ID: 26505634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.
    Mishra S; Rai U; Shiratsuchi T; Li X; Vanloubbeeck Y; Cohen J; Nussenzweig RS; Winzeler EA; Tsuji M; Nussenzweig V
    Vaccine; 2011 Oct; 29(43):7335-42. PubMed ID: 21807053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient induction of protective anti-malaria immunity by recombinant adenovirus.
    Rodrigues EG; Zavala F; Nussenzweig RS; Wilson JM; Tsuji M
    Vaccine; 1998 Nov; 16(19):1812-7. PubMed ID: 9795385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.